Literature DB >> 1335336

S-nitroso-glutathione inhibits platelet activation in vitro and in vivo.

M W Radomski1, D D Rees, A Dutra, S Moncada.   

Abstract

1. The effect of S-nitroso-glutathione (GSNO), a stable nitrosothiol, on platelet activation was examined in vitro and in vivo. 2. The adhesion of human platelets to fibrillar collagen and human endothelial cell monolayers was inhibited by GSNO. 3. GSNO caused a concentration-dependent inhibition of collagen-induced platelet aggregation in vitro and decreased ADP-induced aggregation in the conscious rat. 4. Inhibition of platelet aggregation in vitro correlated with the increase in intraplatelet cyclic GMP levels. 5. The release of NO from GSNO was enhanced by platelet lysate, native glutathione and ascorbate. 6. The results show that GSNO is a carrier of NO and therefore has pharmacological activity as an inhibitor of platelet activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335336      PMCID: PMC1907743          DOI: 10.1111/j.1476-5381.1992.tb14517.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  S-nitrosocysteine inhibition of human platelet secretion is correlated with increases in platelet cGMP levels.

Authors:  E H Lieberman; S O'Neill; M E Mendelsohn
Journal:  Circ Res       Date:  1991-06       Impact factor: 17.367

Review 2.  Glutathione.

Authors:  A Meister; M E Anderson
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

3.  Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

4.  An improved method for washing of human platelets with prostacyclin.

Authors:  M Radomski; S Moncada
Journal:  Thromb Res       Date:  1983-05-15       Impact factor: 3.944

5.  Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule.

Authors:  M D Pierschbacher; E Ruoslahti
Journal:  Nature       Date:  1984 May 3-9       Impact factor: 49.962

6.  An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

7.  Simple method of aequorin loading into platelets using dimethyl sulfoxide.

Authors:  A Yamaguchi; H Suzuki; K Tanoue; H Yamazaki
Journal:  Thromb Res       Date:  1986-10-15       Impact factor: 3.944

8.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds.

Authors:  J S Stamler; D I Simon; J A Osborne; M E Mullins; O Jaraki; T Michel; D J Singel; J Loscalzo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

9.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

10.  Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols.

Authors:  L J Ignarro; C A Gruetter
Journal:  Biochim Biophys Acta       Date:  1980-08-13
View more
  78 in total

Review 1.  Routes for formation of S-nitrosothiols in blood.

Authors:  Enika Nagababu; Joseph M Rifkind
Journal:  Cell Biochem Biophys       Date:  2013-11       Impact factor: 2.194

2.  Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.

Authors:  I L Megson; N Sogo; F A Mazzei; A R Butler; J C Walton; D J Webb
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets.

Authors:  Anna Radomski; Paul Jurasz; Esmond J Sanders; Christopher M Overall; Heather F Bigg; Dylan R Edwards; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

4.  S-Nitrosoglutathione administration ameliorates cauda equina compression injury in rats.

Authors:  Anandakumar Shunmugavel; Mushfiquddin Khan; Marcus M Martin; Anne G Copay; Brian R Subach; Thomas C Schuler; Inderjit Singh
Journal:  Neurosci Med       Date:  2012-09-25

5.  Nanoparticle-induced platelet aggregation and vascular thrombosis.

Authors:  Anna Radomski; Paul Jurasz; David Alonso-Escolano; Magdalena Drews; Maria Morandi; Tadeusz Malinski; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

6.  Feedback inhibition of nitric oxide synthase activity by nitric oxide.

Authors:  J Assreuy; F Q Cunha; F Y Liew; S Moncada
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

7.  Nitric oxide-releasing xerogel-based fiber-optic pH sensors.

Authors:  Kevin P Dobmeier; Gregory W Charville; Mark H Schoenfisch
Journal:  Anal Chem       Date:  2006-11-01       Impact factor: 6.986

8.  Hydrogen peroxide at low concentrations strongly enhances the inhibitory effect of nitric oxide on platelets.

Authors:  K M Naseem; K R Bruckdorfer
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

9.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

Authors:  R De Caterina; P Libby; H B Peng; V J Thannickal; T B Rajavashisth; M A Gimbrone; W S Shin; J K Liao
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 10.  In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide.

Authors:  B Mayer; E R Werner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.